Skip to main content
SpringerLink
Log in

ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006

  • Abstracts
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tanvetyanon T, Stiff PJ. Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol. 2006 Jun; 17(6): 897–907

    Article  PubMed  CAS  Google Scholar 

  2. Vastag B. Consumer groups look to improve adverse event reporting systems. J Natl Cancer Inst 2005 Dec 21; 97(24): 1804–5

    Article  PubMed  Google Scholar 

  3. Munier A, Gras V, Andrejak M, et al. Zoledronic Acid and renal toxicity: data from French adverse effect reporting database. Ann Pharmacother 2005 Jul-Aug; 39(7-8): 1194–7

    Article  PubMed  CAS  Google Scholar 

  4. Linnebur SA, Milchak JL. Assessment of oral bisphosphonate use in elderly patients with varying degrees of kidney function. Am J Geriatr Pharmacother 2004 Dec; 2(4): 213–8

    Article  PubMed  CAS  Google Scholar 

  5. Purcell PM, Boyd IW. Bisphosphonates and osteonecrosis of the jaw. Med J Aust 2005 Apr 18; 182(8): 417–8

    PubMed  Google Scholar 

  6. Robinson NA, Yeo JF. Bisphosphonates—a word of caution. Ann Acad Med Singapore 2004 Jul; 33(4 Suppl): 48–9 Review.

    PubMed  CAS  Google Scholar 

  7. Taiwan National Adverse Drug Reaction Reporting electronic database.

Download references

Author information

Authors and Affiliations

  1. National ADR Reporting Center in Taiwan, Taiwan Drug Relief Foundation, Taipei, Taiwan

    W. W. Chen

  2. School of Pharmacy, National Taiwan University, Taipei, Taiwan

    C. S. Gau

  3. National ADR Reporting System in Taiwan, Taiwan, Taiwan Drug Relief Foundation, Taipei, Taiwan

    C. S. Gau

  4. Center for Drug Evaluation, Taipei, Taiwan

    C. S. Gau

Authors
  1. W. W. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. S. Gau
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, W.W., Gau, C.S. ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006. Drug-Safety 29, 933 (2006). https://doi.org/10.2165/00002018-200629100-00030

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200629100-00030

Keywords

Search

Navigation